Literature DB >> 15622568

Long-term survival after local excision for T1 carcinoma of the rectum.

Riccardo Nascimbeni1, Santhat Nivatvongs, Dirk R Larson, Lawrence J Burgart.   

Abstract

PURPOSE: Many authors have reported high rates of local recurrence after local excision for early carcinoma of the rectum, which raises the question of whether oncologic resection gives better results. This study was designed to compare the long-term recurrence rate, long-term survival, and risk factors for T1 adenocarcinoma of the rectum treated with local excision or oncologic resection.
METHODS: We identified 144 patients who had T1 sessile adenocarcinoma in the lower third or middle third of the rectum. Patients who received adjuvant therapy or who had pedunculated lesions were excluded. Data included age, gender, size of lesion, histologic type of carcinoma, grade, presence of lymphovascular invasion, and depth of invasion. Outcomes were defined as five-year and ten-year cumulative probabilities of local recurrence, distant metastasis, overall survival, and cancer-free survival. The mean follow-up was 9.2 years; median follow-up was 8.1 years.
RESULTS: We compared 70 patients who underwent local excision with 74 patients who underwent oncologic resection. Among patients with lesions in the middle or lower third of the rectum, 1) the five-year and ten-year outcomes were significantly better for overall survival and cancer-free survival in the oncologic resection group, but there were no significant differences in local recurrence or distant metastasis; 2) the multivariate risk factors for long-term, cancer-free survival were invasion into the lower third of the submucosa, local excision, and older than aged 68 years; and 3) for lesions with invasion into the lower third of the submucosa, the oncologic resection group had lower rates of distant metastasis and better survival. Among patients with lesions in the lower third of the rectum, 1) the five-year and ten-year outcomes showed no significant differences in survival, local recurrence, or distant metastasis between the two groups; and 2) for lesions with invasion into the lower third of the submucosa, the oncologic resection group showed a trend of improved survival, which was not statistically significant, possibly because of low statistical power from the small sample size.
CONCLUSIONS: Patients who undergo local excision or oncologic resection for T1 carcinoma in the lower two-thirds of the rectum have a high incidence of local recurrence and distant metastasis. To improve the cure rate, the rate of recurrence must decrease. A randomized, controlled study is needed to determine whether adjuvant therapy may be beneficial.

Entities:  

Mesh:

Year:  2004        PMID: 15622568     DOI: 10.1007/s10350-004-0706-9

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  24 in total

1.  Prognostic factors for 5-year survival after local excision of rectal cancer.

Authors:  Dong-Bing Zhao; Yong-Kai Wu; Yong-Fu Shao; Cheng-Feng Wang; Jian-Qiang Cai
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

2.  The Role of Transanal Surgery in the Management of T1 Rectal Cancers.

Authors:  Imran Hassan; Paul E Wise; David A Margolin; James W Fleshman
Journal:  J Gastrointest Surg       Date:  2015-06-06       Impact factor: 3.452

3.  Transanal endoscopic microsurgery: impact on fecal incontinence and quality of life.

Authors:  Anneke Planting; P Terry Phang; Manoj J Raval; Carl J Brown
Journal:  Can J Surg       Date:  2013-08       Impact factor: 2.089

4.  Are we doing too much?: local excision before radical surgery in early rectal cancer.

Authors:  Sun Min Park; Bong-Hyeon Kye; Min Ki Kim; Heba E Jalloun; Hyeon-Min Cho; In Kyu Lee
Journal:  Int J Colorectal Dis       Date:  2018-02-14       Impact factor: 2.571

5.  T1 adenocarcinoma of the rectum: transanal excision or radical surgery?

Authors:  David J Bentrem; Satoshi Okabe; W Douglas Wong; Jose G Guillem; Martin R Weiser; Larissa K Temple; Leah S Ben-Porat; Bruce D Minsky; Alfred M Cohen; Philip B Paty
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

6.  Outcomes of Local Excision plus Chemoradiotherapy in Patients with T1 Rectal Cancer.

Authors:  Toshiyuki Suzuki; Sotaro Sadahiro; Akira Tanaka; Kazutake Okada; Gota Saito; Hiroshi Miyakita; Takeshi Akiba; Hiroshi Yamamuro
Journal:  Oncology       Date:  2018-06-15       Impact factor: 2.935

7.  Local Excision vs. Radical Resection in T1-2 Rectal Carcinoma: Results of a Study From the Surveillance, Epidemiology, and End Results (SEER) Registry Data.

Authors:  L J Hazard; D C Shrieve; B Sklow; L Pappas; K M Boucher
Journal:  Gastrointest Cancer Res       Date:  2009-05

8.  Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database.

Authors:  Y Nancy You; Nancy N Baxter; Andrew Stewart; Heidi Nelson
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  Radical surgery for early colorectal cancer--anachronism or oncologic necessity?

Authors:  Franz Georg Bader; Uwe Johannes Roblick; Elisabeth Oevermann; Hans-Peter Bruch; Oliver Schwandner
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

10.  Long-term results of local excision for T1 rectal carcinoma: the experience of two colorectal units.

Authors:  Alexander Lebedyev; Hagit Tulchinsky; Micha Rabau; Joseph M Klausner; Michael Krausz; Simon D Duek
Journal:  Tech Coloproctol       Date:  2009-07-31       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.